Psyence Biomedical Ltd.
PBM · NASDAQ
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | $2 | $3,901 | $164,612 | $152,283 |
| - Cash | $6 | $1 | $0 | $1 |
| + Debt | $0 | $10 | $1 | $0 |
| Enterprise Value | -$4 | $3,910 | $164,613 | $152,282 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | $1 | -$51 | -$1 | -$0 |
| % Margin | – | – | – | – |
| Net Income | $1 | -$51 | $8 | $8 |
| % Margin | – | – | – | – |
| EPS Diluted | 1.78 | -7.85 | -0.64 | 0.25 |
| % Growth | 122.7% | -1,126.6% | -356% | – |
| Operating Cash Flow | -$4 | -$3 | -$1 | -$1 |
| Capital Expenditures | -$0 | -$0 | $0 | $0 |
| Free Cash Flow | -$4 | -$3 | -$1 | -$1 |